203 related articles for article (PubMed ID: 16288851)
21. Effects of Ketamine on perceptual grouping in rats.
Kurylo DD; Gazes Y
Physiol Behav; 2008 Sep; 95(1-2):152-6. PubMed ID: 18571682
[TBL] [Abstract][Full Text] [Related]
22. Cataleptic activity of the denatured venom of the social wasp Agelaia vicina (Hymenoptera, Vespidae) in Rattus norvegicus (Rodentia, Muridae).
de Oliveira L; Cunha AO; Mortari MR; Coimbra NC; Dos Santos WF
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):198-203. PubMed ID: 16310919
[TBL] [Abstract][Full Text] [Related]
23. Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system.
Machado DG; Bettio LE; Cunha MP; Capra JC; Dalmarco JB; Pizzolatti MG; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):642-50. PubMed ID: 19286446
[TBL] [Abstract][Full Text] [Related]
24. Neonatal NMDA receptor antagonist treatments have no effects on prepulse inhibition of postnatal day 25 Sprague-Dawley rats.
Boctor SY; Ferguson SA
Neurotoxicology; 2009 Jan; 30(1):151-4. PubMed ID: 19038286
[TBL] [Abstract][Full Text] [Related]
25. Dose-response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity.
Imre G; Fokkema DS; Den Boer JA; Ter Horst GJ
Brain Res Bull; 2006 Apr; 69(3):338-45. PubMed ID: 16564431
[TBL] [Abstract][Full Text] [Related]
26. Memantine and recognition memory: possible facilitation of its behavioral effects by the nitric oxide (NO) donor molsidomine.
Pitsikas N; Sakellaridis N
Eur J Pharmacol; 2007 Oct; 571(2-3):174-9. PubMed ID: 17628527
[TBL] [Abstract][Full Text] [Related]
27. Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test.
Skolnick P; Kos T; Czekaj J; Popik P
Acta Neuropsychiatr; 2015 Aug; 27(4):228-34. PubMed ID: 25858023
[TBL] [Abstract][Full Text] [Related]
28. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
Wesołowska A; Nikiforuk A; Stachowicz K; Tatarczyńska E
Neuropharmacology; 2006 Sep; 51(3):578-86. PubMed ID: 16828124
[TBL] [Abstract][Full Text] [Related]
29. Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome.
Nisijima K; Shioda K; Yoshino T; Takano K; Kato S
Pharmacopsychiatry; 2004 Mar; 37(2):57-62. PubMed ID: 15048612
[TBL] [Abstract][Full Text] [Related]
30. Effects of the 5-HT(3) receptor antagonist ondansetron on the ketamine- and dizocilpine-induced place preferences in mice.
Suzuki T; Aoki T; Kato H; Yamazaki M; Misawa M
Eur J Pharmacol; 1999 Dec; 385(2-3):99-102. PubMed ID: 10607864
[TBL] [Abstract][Full Text] [Related]
31. NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia.
Kapur S; Seeman P
Mol Psychiatry; 2002; 7(8):837-44. PubMed ID: 12232776
[TBL] [Abstract][Full Text] [Related]
32. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
Dawson LA; Hughes ZA; Starr KR; Storey JD; Bettelini L; Bacchi F; Arban R; Poffe A; Melotto S; Hagan JJ; Price GW
Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine.
Chan MH; Chiu PH; Lin CY; Chen HH
Schizophr Res; 2012 Apr; 136(1-3):96-103. PubMed ID: 22325078
[TBL] [Abstract][Full Text] [Related]
34. Impact of postnatal blockade of N-methyl-D-aspartate receptors on rat behavior: a search for a new developmental model of schizophrenia.
Wedzony K; Fijal K; Mackowiak M; Chocyk A; Zajaczkowski W
Neuroscience; 2008 Jun; 153(4):1370-9. PubMed ID: 18434025
[TBL] [Abstract][Full Text] [Related]
35. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
de Boer SF; Koolhaas JM
Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
[TBL] [Abstract][Full Text] [Related]
36. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
Bonaventure P; Kelly L; Aluisio L; Shelton J; Lord B; Galici R; Miller K; Atack J; Lovenberg TW; Dugovic C
J Pharmacol Exp Ther; 2007 May; 321(2):690-8. PubMed ID: 17314195
[TBL] [Abstract][Full Text] [Related]
37. Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity.
Galici R; Boggs JD; Miller KL; Bonaventure P; Atack JR
Behav Pharmacol; 2008 Mar; 19(2):153-9. PubMed ID: 18332680
[TBL] [Abstract][Full Text] [Related]
38. Effects of age and sex on ketamine-induced hyperactivity in rats.
Wilson C; Kercher M; Quinn B; Murphy A; Fiegel C; McLaurin A
Physiol Behav; 2007 Jun; 91(2-3):202-7. PubMed ID: 17400259
[TBL] [Abstract][Full Text] [Related]
39. [5-HT1A/1B receptors, alpha2-adrenoceptors and the post-receptor adenylate cyclase activation in the mice brain are involved in the antidepressant-like action of agmatine].
Jiang XZ; Li YF; Zhang YZ; Chen HX; Li J; Wang NP
Yao Xue Xue Bao; 2008 May; 43(5):467-73. PubMed ID: 18717332
[TBL] [Abstract][Full Text] [Related]
40. Neuroactive steroid dehydroepiandrosterone sulfate inhibits 5-hydroxytryptamine (5-HT)-evoked glutamate release via activation of sigma-1 receptors and then inhibition of 5-HT3 receptors in rat prelimbic cortex.
Dong L; Zhu Y; Dong Y; Yang J; Zhao Y; Qi Y; Wu P; Zhu Y; Zheng P
J Pharmacol Exp Ther; 2009 Aug; 330(2):494-501. PubMed ID: 19420298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
